GMP pharmaceutical manufacturing with active biologics and packaging technology transfer
MSD Ireland operates a regulated pharmaceutical manufacturing site focused on small and large molecule therapeutics, with heavy investment in spray-drying capacity and biologics technology transfer. The hiring profile is manufacturing-heavy (15 of 32 open roles), with senior and director-level gaps in operations and quality, suggesting active facility expansion and compliance infrastructure scaling. Tech stack reveals a traditional pharma ops model: SAP for ERP, DeltaV and Siemens for process automation, Veeva for quality documentation, and legacy industrial protocols (Modbus, PROFINET, OPC) — typical for GMP environments but absent modern cloud or data-platform investment.
Notable leadership hires: Spray Drying Lead, Site Lead Auditor, Maintenance Lead, QC Bioassay Lead, QC Biochemistry Lead
MSD Ireland is the Irish operations hub for Merck & Co., a research-intensive biopharmaceutical manufacturer. The site manufactures medicines and vaccines across therapeutic areas including oncology, infectious disease, and animal health. Current operational scope includes small and large molecule synthesis, biologics formulation (new spray-drying facility under installation), and packaging technology transfer. The facility operates under GMP standards and manages multiple quality and regulatory workstreams: process improvements, supplier qualification, internal/external audits, and deviation tracking. Manufacturing footprint spans Ireland, Netherlands, Italy, and the United States.
SAP (ERP), DeltaV and Siemens TIA (process automation), OSI PI (historian), Veeva Quality Docs (quality management), MES, and industrial protocols including Modbus TCP, PROFINET, and OPC.
Small and large molecule therapeutics, biologics formulations (new spray-drying facility in progress), and finished packaged goods. Product focus includes oncology, infectious disease, and animal health vaccines.
Other companies in the same industry, closest in size